跳至主要内容
临床试验/NCT06656832
NCT06656832招募中不适用

Peripheral Drivers of Heart Failure Progression - The Prospective PEDAL-HF Study

University of Leipzig1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2024年11月28日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,000
试验地点
1
主要终点
Change in NT-proBNP plasma levels between baseline and 6 months visit

研究概览

简要总结

PEDAL-HF is a registry-based randomized prospective multicenter study. The investigators plan to include 1000 patients who were recently admitted with acute decompensated heart failure at five tertiary heart clinics in Germany. For the randomised part, 750 patients will be randomized to care within a heart failure network or usual care. The primary endpoint of the randomized trial is change in NT-proBNP from baseline to 6 months of follow-up.

All patients (randomized or not) will be followed for two years.

详细描述

See above.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

The primary endpoint (NT-proBNP) will be measured by lab personnel blinded to patients´ group assignment

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients admitted to the participating study centres with acute decompensated heart failure (ADHF), defined as clinical signs and/or symptoms of heart failure
  • •objective structural cardiac abnormalitites according to the ESC criteria.

排除标准

  • •Age <18 years
  • •pregnancy
  • •any condition interfering with the informed consent process
  • •patients placed in an institution by official or court order

研究组 & 干预措施

Registry Arm for non-randomised patients

No Intervention

Patients not willing to be randomised will be followed in a registry.

Randomised Arm 1: Heart Failure Network Care

Experimental

Patients will receive three follow-up visits during the vulnerable period (three month after hospital discharge) in the HF network (either cardiologist in private practice or HF outpatient clinic)

干预措施: Heart Failure network care (Other)

Randomised Arm 2: Usual care

No Intervention

Patients will receive usual care by their primary physician or cardiologist

结局指标

主要结局

Change in NT-proBNP plasma levels between baseline and 6 months visit

时间窗: 6 months

Adjusted geometric mean ratio between 6 months visit and baseline visit

次要结局

  • Change in KCCQ from baseline to 6 months of Follow-up(6 months)

研究者

发起方
University of Leipzig
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验